Actively Recruiting
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-01-20
1365
Participants Needed
3
Research Sites
574 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators are doing this research study to assess the percentage of patients receiving stem cell transplantation for the type of blood cancer you have. They want to know how many patients get a transplant and why some patients do get a transplant while others do not. Also they want to explore why some patients elect not to undergo stem cell transplantation, when it is recommended by their physicians.
CONDITIONS
Official Title
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with newly diagnosed or relapsed acute leukemia, including those undergoing reinduction due to primary induction failure
- Patients diagnosed with MDS, MPN, or MDS/MPN overlap who meet criteria such as significant cytopenia, bone marrow blasts over 5%, disease progression, or specific risk scores
- Patients with myelofibrosis meeting low risk or higher DIPSS criteria with anemia, circulating blasts, or adverse cytogenetics
- Patients with acute leukemia or MDS/MPN who relapse after first allografts
- Patients aged 18 to 80 years
- Relapse defined as re-emergence of abnormal myeloid blasts of 5% or more or any relapse prompting treatment intervention
You will not qualify if you...
- Patients diagnosed with polycythemia vera (PV)
- Patients diagnosed with essential thrombocytosis (ET)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Hartford Healthcare Cancer Institute @ Hartford Hospital
Hartford, Connecticut, United States, 06102
Actively Recruiting
2
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Actively Recruiting
3
Lehigh Valley Health Network
Allentown, Pennsylvania, United States, 18103
Active, Not Recruiting
Research Team
R
Roni Tamari, MD
CONTACT
S
Sergio Giralt, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here